Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA
Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.